Evidence-backed European AI register
kaiko.ai
Reviewed identity, roles, model listings, pricing and evidence for kaiko.ai.
Dataset compiled 2026-08-27 · evidence over inference
Reviewed identity
- Headquarters scope
- European non-EU headquarters
- Headquarters record
- Zurich (with a significant Amsterdam presence)
- Legal entity
- AG
- Ownership
- privately funded; backed by Nadia Schadlow-linked and Dutch/Swiss investors, with a long-running partnership with the Netherlands Cancer Institute
- Founded
- 2020
- Confidence
- medium
- Last verified
- 2026-08-22
Evidence boundaries
Organisation listings identify a reviewed canonical record. Model listings show an association in the source register; they do not by themselves establish model creation, current API availability, hosting location or infrastructure ownership.
Model listings
- Midnight-12k
- Type
- multimodal
- Parameters
- unknown
- Context
- unknown
- Languages
- n/a — histopathology whole-slide images
- Licence
- MIT
- Release
- 2025-04
- Type
- multimodal
- Parameters
- ViT-S to ViT-L class
- Context
- unknown
- Languages
- n/a — histopathology
- Licence
- open source
- Release
- 2024-04
- eva (open-source evaluation framework for pathology foundation models)
- Type
- text
- Parameters
- unknown
- Context
- unknown
- Languages
- n/a — benchmark harness
- Licence
- Apache-2.0
- Release
- 2024
Profile note
Zurich medical AI lab that releases genuinely open (MIT) pathology foundation models — Midnight-12k matches or beats Virchow2 and UNI-2 while training on orders of magnitude less data — and maintains eva, the open evaluation framework the whole field now benchmarks against. Directly comparable to Berlin's Aignostics but far more open. No pricing; open weights.